Literature DB >> 3732313

Severe congenital factor X deficiency with intracranial haemorrhage.

T Sumer, M Ahmad, N K Sumer, M I Al-Mouzan.   

Abstract

A Saudi Arabian infant with severe factor X deficiency who had had two intracranial haemorrhages is described. Attempts to raise his factor X level and improve his prothrombin time (PT) and partial thromboplastin time (PTT) by using vitamin K, oestradiol and danazol have failed. New therapeutic trials are necessary for patients with severe forms of this rare disorder.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3732313     DOI: 10.1007/bf00441870

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  7 in total

1.  THE INHERITANCE OF STUART DISEASE: INVESTIGATION OF A FAMILY WITH FACTOR X DEFICIENCY.

Authors:  E LECHLER; W P WEBSTER; H R ROBERTS; G D PENICK
Journal:  Am J Med Sci       Date:  1965-03       Impact factor: 2.378

2.  A new coagulation defect.

Authors:  T P TELFER; K W DENSON; D R WRIGHT
Journal:  Br J Haematol       Date:  1956-07       Impact factor: 6.998

3.  Increased clotting factors in pregnacy.

Authors:  L PECHET; B ALEXANDER
Journal:  N Engl J Med       Date:  1961-11-30       Impact factor: 91.245

4.  Congenital Stuart-Prower factor (factor X) deficiency.

Authors:  B M Sarup; A Perkash; B K Aikat
Journal:  J Indian Med Assoc       Date:  1972-08-01

5.  Therapeutic approaches to factor X deficiency with emphasis on the use of a new clotting-factor concentrate (Konyne).

Authors:  D S O'Leary; F B Ruymann; M E Conrad
Journal:  J Lab Clin Med       Date:  1971-01

6.  Danazol increases factor VIII and factor IX in classic hemophilia and Christmas disease.

Authors:  H R Gralnick; M E Rick
Journal:  N Engl J Med       Date:  1983-06-09       Impact factor: 91.245

7.  Congenital factor X deficiency in Japan.

Authors:  K Mori; H Sakai; N Nakano; S Suzuki; K Sugai; S Hisa; Y Goto
Journal:  Tohoku J Exp Med       Date:  1981-01       Impact factor: 1.848

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.